Interpace Biosciences, Inc.
IDXG· OTC
IDXGInterpace Biosciences, Inc.
Filed Nov 6, 2012 · 10-Q · 37 days after period end · 0001054102-12-000033
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $31.78M | $36.07M | $35.97M |
| Net Income | -$1.02M | -$202.00K | -$1.67M |
| EPS Diluted | -$0.07 | -$0.01 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Interpace Biosciences, Inc. · CIK 1054102 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 6, 2012 · 37 d after period end
